AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
AC Immune – Figure 1
All stock acquisition & PIPE maintains and enhances AC Immune’s strong cash position.
All stock acquisition & PIPE maintains and enhances AC Immune’s strong cash position.
Figure 2
ACIU moves to the forefront of Parkinson’s drug development
…
